Sanofi is planning to cut the U.S. price of its most-prescribed insulin by 78% and cap monthly out-of-pocket costs at $35 for people who have private insurance. CNBC
It comes after Eli Lilly and Novo Nordisk made similar sweeping price cuts earlier this month.on Thursday said it's planning to cut the U.S. price of its most popular insulin drug by 78% and cap monthly out-of-pocket costs at $35 for people who have private insurance starting next year.
In addition to its widely prescribed Lantus, the French drugmaker will reduce the list price of its short-acting insulin Apidra by 70%. Sanofi already offers a $35 monthly cap on insulin for uninsured diabetes patients. The company is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts for the lifesaving hormone.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Sanofi to cut US price of its most-prescribed insulin by 78%Sanofi SA said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly and Co .
Consulte Mais informação »
Sanofi to cut US price of its most-prescribed insulin by 78%Sanofi SA said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly and Co .
Consulte Mais informação »
Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%French drugmaker Sanofi SA said it would cut the price of some of its insulin products by as much as 78% in the U.S., joining other big diabetes drugmakers facing pressure over high costs.
Consulte Mais informação »
Blink's Smart Doorbell is just $35 on Amazon right nowThe amazon-owned company has marked its video doorbell back down to its lowest price ever for the first time since the holiday season.
Consulte Mais informação »
Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured | CNNSanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.
Consulte Mais informação »
Mission Valley River Crossings Closed After Storm Drenches San Diego; Flooded SR-78 Closed WestboundNon-stop overnight rain from the latest in a series of atmospheric river storms to reach San Diego County flooded streets, prompted dozens of crashes on rain-slicked roadways and downed trees across the county Wednesday.
Consulte Mais informação »